Align Technology Inc. stock (US0162551016): Nasdaq price steadies ahead of next earnings window

Align Technology Inc. shares on the Nasdaq in the United States have been trading in a relatively steady band in recent weeks after the company released its first-quarter 2026 results at the end of April, keeping attention on how the clear-aligner specialist may navigate demand trends and macro headwinds in the coming quarters, according to data from Nasdaq and company disclosures.

The stock, listed under the ticker ALGN on Nasdaq, last closed at around the mid-USD 170s toward the end of May 2026, according to Nasdaq price data as of 05/29/2026, placing the company’s equity value firmly in the mid-cap range on the U.S. market and underscoring its role in the domestic medical-device landscape.

At that level, the shares remain well below their highs from earlier cycles yet above trough levels seen during past industry slowdowns, leaving U.S. investors focused on how Align Technology’s growth profile and profitability might evolve as it continues to sell digital orthodontic solutions globally, according to price and trading history published by Nasdaq as of 05/29/2026.

From a liquidity perspective, trading volumes on Nasdaq in late May 2026 indicated that the stock continues to see active participation from both institutional and retail investors in the United States, which is important for order execution quality and bid-ask spreads in a market segment characterized by specialized healthcare names.

While there has been no new formal guidance update or major corporate action filed with the U.S. Securities and Exchange Commission in the second half of May 2026, the market is still digesting the company’s most recent quarterly numbers and commentary, as well as positioning for the next earnings date, according to the firm’s investor relations materials and recent filings.

The company had previously announced that it would report financial results for the first quarter of 2026 on 04/29/2026 after the close of U.S. trading, with the details made available through the investor relations section of its website, according to a Business Wire press release dated 03/31/2026 and filed from its U.S. headquarters in Tempe, Arizona.

Those first-quarter 2026 results, released on 04/29/2026, provided updated information on revenue, margins and regional performance, and they continue to anchor how investors in the United States assess the trajectory of the Invisalign clear aligner and iTero scanner franchises heading into mid-2026, according to the company’s quarterly report and accompanying webcast materials.

As of 05/29/2026, the stock traded near USD 175 on Nasdaq, according to market data collated by MarketBeat and other U.S. market platforms, offering a concrete reference point for investors reviewing the name against broader U.S. indices such as the Nasdaq Composite and S&P 500.

In Germany, the shares trade via venues such as Tradegate in euros, giving European investors an additional access point and providing a bridge for German-speaking market participants who follow U.S.-listed medical-technology companies.

As of: 05/31/2026

By the editorial team - specialized in equity coverage.

Align Technology Inc.: core business model

Align Technology generates its revenue by providing orthodontists and dentists worldwide with digital orthodontic ecosystems built around Invisalign clear aligners, iTero scanners and exocad software, with growth closely tied to procedure volumes and adoption of digital treatment planning.

Chart technicals and 52-week range

From a technical perspective, Align Technology Inc. shares have moved within a broad range over the past 52 weeks, reflecting shifts in sentiment toward U.S. growth stocks and healthcare-exposed names, as well as company-specific news such as quarterly earnings and guidance updates, according to Nasdaq trading history as of late May 2026.

The stock’s 52-week low sits meaningfully below current trading levels, while the 52-week high remains substantially above the recent May 2026 price point, indicating that the name has experienced periods of both pressure and recovery over the past year; investors watching the chart often cross-check these levels with commonly followed moving averages and relative-strength indicators when assessing momentum, based on chart data from U.S. market platforms as of 05/29/2026.

Conclusion

With Align Technology Inc. trading on Nasdaq at a level that reflects mixed sentiment toward growth-oriented medical-technology stocks, investors continue to anchor their views on the company’s April 2026 first-quarter results and the outlook that management set out at that time.

The technical picture, including the 52-week trading range and recent consolidation phase, frames how market participants in the United States and Europe weigh potential upside from clear-aligner adoption against macroeconomic and competitive risks in the digital dentistry space.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.